HUE062529T2 - Ibuprofén és tramadol kombinációja fájdalom csillapítására - Google Patents

Ibuprofén és tramadol kombinációja fájdalom csillapítására

Info

Publication number
HUE062529T2
HUE062529T2 HUE20740266A HUE20740266A HUE062529T2 HU E062529 T2 HUE062529 T2 HU E062529T2 HU E20740266 A HUE20740266 A HU E20740266A HU E20740266 A HUE20740266 A HU E20740266A HU E062529 T2 HUE062529 T2 HU E062529T2
Authority
HU
Hungary
Prior art keywords
tramadol
ibuprofen
combination
relieving pain
relieving
Prior art date
Application number
HUE20740266A
Other languages
English (en)
Hungarian (hu)
Inventor
Perez Antonio Portoles
Serna Luis Narciso Sante
Butron Maria Del Rosario Salas
Castrillon Emilio Vargas
Perez Carlos Calandria
Cordoba Raquel Horcajada
Ruiz Angel Jose Munoz
De La Torre Marta Vicario
Menendez Nuria Sanz
Calvo Antonia Gomez
Garcia Jose Angel Sanchez
Gonzalez Ester Duart
Alonso Fernando Garcia
Original Assignee
Farmalider Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmalider Sa filed Critical Farmalider Sa
Publication of HUE062529T2 publication Critical patent/HUE062529T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
HUE20740266A 2019-07-09 2020-07-08 Ibuprofén és tramadol kombinációja fájdalom csillapítására HUE062529T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP19382583 2019-07-09

Publications (1)

Publication Number Publication Date
HUE062529T2 true HUE062529T2 (hu) 2023-11-28

Family

ID=67480112

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE20740266A HUE062529T2 (hu) 2019-07-09 2020-07-08 Ibuprofén és tramadol kombinációja fájdalom csillapítására

Country Status (21)

Country Link
US (1) US12514833B2 (https=)
EP (1) EP3996699B1 (https=)
JP (1) JP7656339B2 (https=)
CN (1) CN114080221B (https=)
AU (1) AU2020309160B2 (https=)
BR (1) BR112022000242A2 (https=)
CA (1) CA3145632C (https=)
DK (1) DK3996699T3 (https=)
ES (1) ES2952013T3 (https=)
FI (1) FI3996699T3 (https=)
HR (1) HRP20230677T1 (https=)
HU (1) HUE062529T2 (https=)
MA (1) MA56341B1 (https=)
MD (1) MD3996699T2 (https=)
MX (1) MX2022000373A (https=)
MY (1) MY207573A (https=)
PL (1) PL3996699T3 (https=)
PT (1) PT3996699T (https=)
RS (1) RS64500B1 (https=)
SI (1) SI3996699T1 (https=)
WO (1) WO2021005129A1 (https=)

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB971700A (en) 1961-02-02 1964-09-30 Boots Pure Drug Co Ltd Anti-Inflammatory Agents
US3652589A (en) 1967-07-27 1972-03-28 Gruenenthal Chemie 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols
GB1497044A (en) 1974-03-07 1978-01-05 Prodotti Antibiotici Spa Salts of phenyl-alkanoic acids
US5516803A (en) * 1991-10-30 1996-05-14 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
AU661723B2 (en) 1991-10-30 1995-08-03 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
IT1264857B1 (it) 1993-06-21 1996-10-17 Zambon Spa Composizione farmaceutica liquida per uso orale contenente acido 2-(4-isobutilfenil) propionico
IT1264855B1 (it) 1993-06-21 1996-10-17 Zambon Spa Composizioni farmaceutiche contenenti sali dell'acido s(+)-2-(4-isobutilfenil) propionico con amminoacidi basici
US6348216B1 (en) 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
WO2000025769A1 (en) 1998-11-02 2000-05-11 Ortho-Mcneil Pharmaceutical, Inc. Analgesic regimen
US6251945B1 (en) 1999-01-14 2001-06-26 Knoll Aktiengesellschaft Pharmaceutical mixture comprising a combination of a profen and other active compounds
US6211246B1 (en) 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
US6342530B1 (en) 2000-11-14 2002-01-29 Farmacon-Il, Llc Composition and method for parenteral administration of ibuprofen d,l- or l-lysine salt
US6727286B2 (en) 2001-11-02 2004-04-27 Cumberland Pharmaceuticals Inc. Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
JP5185488B2 (ja) 2001-11-02 2013-04-17 カンバーランド ファーマシューティカルズ，インコーポレーテッド ２−（４−イソブチルフェニル）プロピオン酸の医薬組成物
ES2287519T3 (es) 2002-10-25 2007-12-16 Dompe S.P.A. Composiciones inyectables indoloras que contienen sal de acidos 2-arilpropionicos.
US20070117826A1 (en) * 2005-11-23 2007-05-24 Forest Laboratories, Inc. Pharmaceutical formulations comprising ibuprofen, oxycodone, and 14-hydroxycodeinone
EP2149546A1 (en) * 2008-07-31 2010-02-03 Laboratorios Del. Dr. Esteve, S.A. Salts of tramadol and ibuprofen and their crystal form in the treatment of pain
WO2010078486A2 (en) 2008-12-31 2010-07-08 Upsher-Smith Laboratories, Inc. Opioid-containing oral pharmaceutical compositions and methods
AU2010224063B2 (en) 2009-03-12 2015-04-16 Cumberland Pharmaceuticals Inc Administration of intravenous ibuprofen
US8735452B2 (en) 2009-07-15 2014-05-27 Cumberland Pharmaceuticals Inc. Treating patients with intravenous ibuprofen
US8871810B2 (en) 2009-07-15 2014-10-28 Cumberland Pharmaceuticals Inc. Treating critically ill patients with intravenous ibuprofen
ES2356762B1 (es) * 2009-09-04 2011-11-24 Farmalider S.A. Composicion farmaceutica de ibuprofeno, tramadol y un aminoacido basico, procedimiento para su preparacion y utilizacion de la misma.
MX2010004974A (es) 2010-05-04 2011-11-23 Senosiain S A De C V Lab Combinacion de un aine y un aminoacido.
CA2833307C (en) 2011-04-12 2018-01-23 Revogenex Inc. Intravenous administration of tramadol
ES2552521T3 (es) 2012-02-20 2015-11-30 Pharmaceutical Solutions Industry Ltd Infusión intravenosa de ibuprofeno
ES2423866B1 (es) 2012-02-22 2014-06-10 Farmalider, S.A. Composición farmaceútica de ibuprofeno y tramadol para inyección
ES2540151B1 (es) * 2013-10-11 2016-02-29 Farmalider S.A. Composición farmacéutica de ibuprofeno y tramadol para uso oftálmico
US20150290211A1 (en) * 2014-04-10 2015-10-15 Locl Pharma, Inc. Pharmaceutical compositions

Also Published As

Publication number Publication date
EP3996699A1 (en) 2022-05-18
EP3996699B1 (en) 2023-06-28
SI3996699T1 (sl) 2023-10-30
AU2020309160B2 (en) 2025-06-26
WO2021005129A1 (en) 2021-01-14
PT3996699T (pt) 2023-07-27
MA56341B1 (fr) 2023-07-31
CN114080221A (zh) 2022-02-22
US12514833B2 (en) 2026-01-06
DK3996699T3 (da) 2023-07-24
BR112022000242A2 (pt) 2022-05-31
CA3145632C (en) 2024-03-12
RS64500B1 (sr) 2023-09-29
MY207573A (en) 2025-03-05
HRP20230677T1 (hr) 2023-10-13
MX2022000373A (es) 2022-02-10
PL3996699T3 (pl) 2023-10-30
JP7656339B2 (ja) 2025-04-03
AU2020309160A1 (en) 2022-02-17
FI3996699T3 (fi) 2023-08-01
CA3145632A1 (en) 2021-01-14
JP2022540854A (ja) 2022-09-20
CN114080221B (zh) 2023-12-05
MD3996699T2 (ro) 2023-11-30
ES2952013T3 (es) 2023-10-26
US20220249414A1 (en) 2022-08-11

Similar Documents

Publication Publication Date Title
IL277234A (en) Systems and methods for treating hemoglobin diseases
SG11202102775VA (en) Systems and methods for enhancing efficacy of ultrasound treatment
SI3947375T1 (sl) Imidazolonilkinolinske spojine in terapevtske uporabe le-teh
IL292810A (en) Therapeutic compounds and methods of use
PL3986347T3 (pl) Opaska uciskowa i kombinacja opaski uciskowej
GB201905520D0 (en) Compounds and their therapeutic use
ZA202207188B (en) Liquid tasimelteon formulations and methods of use thereof
GB201918541D0 (en) Therapeutic compounds and their use
IL272036A (en) Methods and compositions for treating pain using capsaicin
IL313081A (en) New HDAC inhibitors and their medical use
GB201918879D0 (en) Treatment of chronic pain
IL291543A (en) Medical preparations and their use
IL284029B1 (en) Peptides for the treatment and prevention of diabetes and related disorders
IL284689A (en) Endoscopic device and methods of its use
IL284032A (en) 3 beta-(benzyloxy)-17 alpha-methyl-paragan-5-en-20-one for use in the treatment of cognitive disorders
GB2600270B (en) Polymer-comrprising medical devices and uses thereof
HUE062529T2 (hu) Ibuprofén és tramadol kombinációja fájdalom csillapítására
IL287955A (en) Use of tramadol and celecoxib co-crystals to treat pain while reducing the potential for tramadol abuse
GB201811737D0 (en) Forceps and method of manufacture and use
IL276228A (en) Compounds and preparations for the treatment of pain
EP3661494B8 (en) Use of tasimelteon for the treatment of affective disorders in majority black african patients
GB201913312D0 (en) Treatment of hypothyroidism and related conditions
HK40071100A (zh) 曲马多和塞来昔布的共晶体用於治疗疼痛同时降低曲马多的滥用倾向的用途
ZA201904326B (en) Treatment of joint pain
GB2603379B (en) Avocatin B for the treatment of diseases and conditions